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ABSTRACT
Phenotypic differences between Campylobacter fetus fetus and C. fetus venerealis
subspecies allow the differential diagnosis of bovine genital campylobacteriosis.
The hydrogen sulfide production, for example, is a trait exclusive to C. fetus fetus and
C. fetus venerealis biovar intermedius. This gas that can be biochemically tested can
be produced from L-cysteine (L-Cys). Herein, we report a novel multiplex-PCR to
differentiate C. fetus based on the evaluation of a deletion of an ATP-binding
cassette-type L-Cys transporter that could be involved in hydrogen sulfide
production, as previously described. A wet lab approach combined with an in silico
whole genome data analysis showed complete agreement between this L-Cys
transporter-PCR and the hydrogen sulfide production biochemical test. This
multiplex-PCR may complement the tests currently employed for the differential
diagnosis of C. fetus.
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INTRODUCTION
Campylobacter fetus is best known as a major veterinary pathogen that has a detrimental
effect on reproductive efficiency of herds. However, in humans, this bacterium can also
cause intestinal illness and, occasionally, severe systemic infections and thus the products
from cattle and sheep are suspected as sources of transmission (Wagenaar et al.,
2014). The classification of C. fetus subspecies relies on clinical features, host specificity,
and phenotypic traits. Despite technical limitations and variable success, hydrogen
sulfide (H2S) production as well as tolerance to glycine and NaCl, selenite reduction
and resistance to antibiotics are the available biochemical tests currently employed as
differential diagnosis of C. fetus (OIE, 2018; Schulze et al., 2006).
Members of C. fetus have different tropism, as evidenced in veterinary practice
and in the diagnosis. The subspecies C. fetus venerealis (Cfv) is restricted to the
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bovine reproductive tract, and is associated to the venereal disease bovine genital
campylobacteriosis (BGC), whereas C. fetus fetus (Cff) is mainly intestinal and is usually
related to sporadic abortion. To date, the bovine products are subjected to strict regulations
by the World Organization for Animal Health (OIE) and must be tested for the
presence of C. fetus subsp. venerealis before international trading (OIE, 2018). Therefore,
its differentiation at the subspecies level is critical. The isolation of the bacteria can confirm
BGC and subsequently biochemical tests can determine the particular different isolates.
Among the biochemical tests, glycine resistance and hydrogen sulfide(H2S) production are
two of the best biochemical performing tests. For example, Cff strains show 1% glycine
resistance and produce H2S in L-cysteine (L-Cys) enriched media. By contrast, Cfv strains
fail to grow in 1% glycine-containing media and to produce H2S (Véron & Chatelain,
1973). Hence, these traits allow their discrimination. A glycine-tolerant variant of Cfv
(C. fetus venerealis biovar intermedius, Cfvi) are frequently isolated in some countries
such as USA, UK, South Africa and Argentina, which complicates their accurate
identification (Schmidt, Venter & Picard, 2010; Van Bergen et al., 2005; Iraola et al.,
2013). A third-host associated subspecies, C. fetus subsp. testudinum, completes the list
of subspecies of C. fetus. This subspecies has been isolated from reptiles and humans
(Fitzgerald et al., 2014) and therefore would not be relevant for animal production.
In a previous wide genome association study, Van der Graaf-van Bloois et al. (2016a)
described a recent diversification of mammalian C. fetus and implicated a genetic
factor associated to H2S production. They described a deletion in an ATP-binding
cassette-type L-Cys transporter in Cfv strains. The operon structure of this L-Cys
transporter has five coding sequences and three of them code for different molecular
components of the transporter: the ATP-binding protein, the permease, and the
substrate-binding protein (locus tags CFF8240_RS03845, CFF8240_RS03850 and
CFF8240_RS03855 in C. fetus 82-40 genome, respectively). This L-Cys importer could be
part of the Class 3 ABC-transporters (Licht & Schneider, 2011) and in Cfv the permease
and the extracellular binding domain coding genes are deleted. This deletion may
impair the transporter assembly, affecting the up-take of L-Cys. This therefore could
explain the impaired production of H2S from this amino acid in Cfv strains. On these
bases, we aimed to develop a simple molecular technique for detecting the L-Cys
transporter-deletion polymorphism with the main purpose of identifying H2S-producing
C. fetus strains.
MATERIALS AND METHODS
Campylobacter fetus isolates and bacterial culture
All the C. fetus isolates (n = 36) were obtained from bovine clinical samples at the
Bacteriology Unit (EEA-INTA Balcarce, Argentina). Thirty of these clinical isolates were
randomly-selected for this study. In addition, the strains Cfv 97/608, Cfv 98/25 and
Cfvi 99/541 were also selected because of the availability of their whole genome sequences
(Van der Graaf-van Bloois et al., 2014; Iraola et al., 2013) and three additional isolates were
selected to perform whole genome sequencing (see below).
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All the C. fetus isolates were grown on 7% blood-Skirrow selective agar plates (Oxoid,
Hampshire, UK) with 1.25 IU/ml polymyxin B sulfate, 5 mg/ml trimethoprim, 10 mg/ml
vancomycin and 50 mg/ml cycloheximide (Sigma-Aldrich, St. Louis, MO, USA). The plates
were incubated under microaerophilic conditions (5% O2, 10% CO2 and 85% N2) for 72 h at
37 C. C. hyointestinalis NCTC11562 and the field isolate C. sputorum 08/209 were grown
under the same conditions. C. coli NCTC11353 and C. jejuni NCTC11392 were cultured on
Blood-Columbia agar plates (Oxoid) under microaerophilic condition for 24 h at 42 C.
Biochemical tests
The classification of the subspecies was performed following standard protocols
(OIE, 2018): sodium selenite reduction, 3.5% sodium chloride resistance, 1% glycine
tolerance and H2S production in 0.02% L-Cys enriched medium. We also tested 1.3%,
1.5% and 1.9% glycine tolerance. The isolates were identified as Cff if they reduced sodium
selenite, produced H2S and showed sodium chloride tolerance and at least 1% glycine
resistance.
DNA isolation
A rapid protocol (freeze-thaw cycles) was applied to obtain the DNA template as follows.
A loopful of each culture was collected and resuspended in 250 µl of sterile deionized
water. Two cycles of freeze and boiling (-80/95 C) were performed and the cellular debris
were discarded after a centrifugation step. Two µl of the supernatant was used as
PCR-template. High quality genomic DNA was obtained using mini spin columns
(NucleoSpin Tissue; Macherey-Nagel GmbH & Co., Duren, Germany). DNA quality was
tested using the Qubit 4 fluorometer (Invitrogen, Carlsbad, CA, USA; Thermo Scientific,
Waltham, MA, USA) and further used for sequencing purpose.
L-Cys transporter-PCR
One forward and two reverse primers (Fwd 5′-gtccatttacttatcacgataacagtgg-3′,
Rev1 5′-gatattaggctaagaggaatggtgtattg-3′ and Rev2 5′-ctcccgtatctacatgaaagctaatatc-3′)
were designed for a multiplex-PCR format using open source Unipro UGENE 1.31
(Okonechnikov et al., 2012) (Fig. 1A). The amplification mix consisted of 1 × GoTaq green
Reaction buffer (1.5 mM MgCl2), 0.25 mM of each dNTP, 0.1 mM of each primer, and
1.25 U Taq polymerase (Promega Corp., Madison, WI, USA), nuclease-free water to reach
a final volume of 25 µl and Campylobacter DNA template.
The touch-down amplification program consisted of an initial step at 94 C for 3 min,
10 cycles at 94 C for 1 min, followed by annealing temperatures starting at 55 C for
1 min and decreasing 1 C per cycle from 55 to 45 C. Then, an extension step was
performed at 72 C for 1 min, followed by 30 cycles with an annealing at 51 C, and a final
termination step at 72 C for 8 min.
Under these conditions, the absence of the expected product of 1,390 bp makes the
interpretation of the PCR results easy. A product of 714-bp is indicative of Cff and Cfvi
strains (which have a complete version of the operon and are H2S-producing strains),
whereas a 310 bp product refers to Cfv strains (which contain a partly deleted operon and
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are non- H2S-producing strains). All the products were resolved in 1.5% agarose gel
electrophoresis and visualized by ethidium bromide staining. The PCR-products were
submitted to the UGB unit-INTA to confirm their identity through Sanger sequencing.
In silico-PCR: whole genome sequencing and genomic data analysis
We selected three isolates from bovine abortions (Cff 13/344, Cff 08/421 and Cfvi 06/341)
of the most productive agricultural areas of Argentina. Paired-end Nextera XT libraries
were constructed and sequenced in a MiSeq sequencer (2 × 250 pb, Illumina). A quality
Figure 1 Differential L-Cys Transporter-PCR. (A) Schematic representation of the organization of the
genes encoding the L-Cys transporter in C. fetus. Primer targeting regions and expected PCR-products are
shown. The gray arrow represents the permease protein YckJ coding gene (locus tag CFF8240_RS03850
in Cff 82-40 genome) which is deleted in Cfv strains. The light gray arrow represents the extra-
cellular-binding protein YckK coding gene (locus tag CFF8240_RS03855), which is partially deleted in
Cfv. ATP-binding protein coding gene (locus tag CFF8240_RS03845) which is another component of the
transporter is conserved in both subspecies and is represented by black arrow. (B) Representative agarose
gel electrophoresis. Lane 1, negative control (water); lane 2, Cff 08/421; lane 3, Cff 96/136; lane 4, Cfvi
06/341; lane 5, Cfv 97/608; lane 6, Cfvi 03/596 and lane 7, Cfv 95/258. Under the set conditions, the
product of 1,390 bp is absent. M: molecular weight marker, 1 kb DNA ladder (Promega).
Full-size DOI: 10.7717/peerj.7820/fig-1
Farace et al. (2019), PeerJ, DOI 10.7717/peerj.7820 4/21
trimming step was applied to raw reads using Trimmomatic (Bolger, Lohse & Usadel,
2014). De novo assembly was done using SPAdes v3.11.1 (Bankevich et al., 2012). Contigs
were oriented using Mauve (Darling et al., 2004; Rissman et al., 2009) and the genome
of C. fetus venerealis 97-608 as a reference (NZ_CP008810.1). The genomes were
annotated using PROKKA (Seemann, 2014) and RASTtk (Brettin et al., 2015).
The assembly summary statistics is shown in Table S1.
In total, whole-genome sequence data of 214 C. fetus strains (Cff, n = 152; Cfv, n = 42;
Cfvi, n = 19 and one strain not identified at the subspecies level, Cf = 1) from 19 countries
and different hosts (bovine, n = 117; human, n = 78; ovine, n = 15; monkey, n = 1 and
unknown, n = 3) were screened to search for the target sequences of the primers designed
for the L-Cys transporter-PCR protocol. These data included the three genomes
obtained in this study (Cff 13/344, Cff 08/421 and Cfvi 06/341) and 37 publicly available
genomes from GenBank. Additionally, reads from C. fetus strains (n = 174) deposited
in ENA database (https://www.ebi.ac.uk/ena/) were also assembled, as mentioned above,
and subsequently analyzed as follows. The Primer map software (http://www.bioinformatics.
org/sms2/primer_map.html) was used for global searching of Fwd, Rev1 and Rev2
primer sequences. Primer Map output is a textual map showing the annealing positions of
PCR primers. Afterwards, several conditions were evaluated, including annealing of
both primers of each pair and their orientation. The position of each target annealing site
was employed to estimate the amplicon size. The program, by default, does not allow
mismatches. Cases where the annealing was confirmed for a single primer were classified
as not detected or unknown.
Statistics
The agreement between the H2S production biochemical test and the L-Cys transporter-PCR
was tested with Cohen´s Kappa statistic.
RESULTS
L-Cys transporter-PCR: wet-lab assay
The multiplexed PCR-based approach herein designed produced a differential band
pattern between the C. fetus isolates with distinct H2S-biochemical test results (Fig. 1B).
This protocol was named L-Cys transporter-PCR. We tested 36 biochemically typed
isolates with this L-Cys transporter-PCR, followed by electrophoresis of the products in
agarose gel to reveal the size of the amplicons. A single amplification product was obtained
in all the tested strains. The retrieved band from Cff and Cfv biovar intermedius (Cfvi)
strains was of 714 bp. This result coincided with a complete version of the L-Cys
transporter operon and this pattern was named “CFF/CFVI.” Amplifications from Cfv
strains generated a smaller product of 310 bp, equivalent to a partially deleted operon, and
this profile was named “CFV” (Fig. 1B). This L-Cys transporter-PCR allowed a differential
testing that avoided a negative result in presence of C. fetus DNA. Indeed, a negative
result, sometimes could be indicative of both the absence of the specific target and the
presence of inhibitors in the sample. As expected, no product was obtained from DNA
of Campylobacter spp. other than C. fetus (C. hyointestinalis, C. coli, C. jejuni and
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Table 1 L-Cys transporter-PCR: analysis of Argentinian C. fetus isolates and Campylobacter spp.
strains.








Cff 96-136 Bahía Blanca, BA + + Cff CFF/CFVI
Cff 08-421 Gral. López, SF + + Cff CFF/CFVI
Cff 14-284 Pila, BA + + Cff CFF/CFVI
Cff 04-240 Olavarría, BA + + Cff CFF/CFVI
Cff 13-344 Balcarce, BA + + Cff CFF/CFVI
Cff 11-572 Balcarce, BA + + Cff CFF/CFVI
Cff 89-222 Balcarce, BA + + Cff CFF/CFVI
Cff 90-189 Balcarce, BA + + Cff CFF/CFVI
Cff CI N3 Balcarce, BA + + Cff CFF/CFVI
Cff 01-165 Santa Rosa, LP + + Cff CFF/CFVI
Cff 01-64 Balcarce, BA + + Cff CFF/CFVI
Cff 05-622 Cnel. Dorrego, BA + + Cff CFF/CFVI
Cff 11-262 Balcarce, BA + + Cff CFF/CFVI
Cff 11-295 Saladillo, BA + + Cff CFF/CFVI
Cff 11-360 Necochea, BA + + Cff CFF/CFVI
Cff 11-685 Balcarce, BA + + Cff CFF/CFVI
Cff 11-408 Necochea, BA + + Cff CFF/CFVI
Cff btu5 BA + + Cff CFF/CFVI
Cff btu6 BA + + Cff CFF/CFVI
Cff btu7 BA + + Cff CFF/CFVI
Cff 18-09 BA + + Cff CFF/CFVI
Cff 18-100 BA + + Cff CFF/CFVI
Cfv 97-608 Hucal, LP − − Cfv CFV
Cfv 95-258 Mar Chiquita, BA − − Cfv CFV
Cfv 08-382 Gral. Belgrano, BA − − Cfv CFV
Cfv 05-355 Balcarce, BA − − Cfv CFV
Cfv 98-25 Gral. Pueyrredón, BA − − Cfv CFV
Cfv 19-01 BA − − Cfv CFV
Cfvi 06-341 Pehuajó BA − + Cfvi CFF/CFVI
Cfvi 03-596 Pehuajó, BA − + Cfvi CFF/CFVI
Cfvi 02-146 BA − + Cfvi CFF/CFVI
Cfvi 98-472 Azul, BA − + Cfvi CFF/CFVI
Cfvi 99-541 Balcarce, BA − + Cfvi CFF/CFVI
Cfvi 07-379 Mar Chiquita, BA − + Cfvi CFF/CFVI
Cfvi 00-305 BA − + Cfvi CFF/CFVI
Cfvi 03-596 Pehuajó, BA − + Cfvi CFF/CFVI
C. sputorum 08-209 Balcarce, BA ND ND ND –
C. coli NCTC11353 National Collection of
Type Cultures, England
ND ND ND –
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C. sputorum) (Table 1). This result confirmed the specificity of this L-Cys transporter-PCR
test for C. fetus.
The results from the L-Cys transporter-PCR analysis displayed a perfect correlation with
the H2S production test (κ = 1). The analysis of concordance between tests is shown in
Table S2.
We also addressed an in silico analysis of genomic sequences from mammalian C. fetus
to further support this conclusion.
L-Cys transporter-PCR : in silico screening
To study the performance of the L-Cys transporter-PCR in a more diverse panel of strains,
we applied an in-silico PCR-strategy by performing searches of the primer targeting
sequences in whole genomes of 214 C. fetus strains (three of which were obtained in this
study by Next-Generation Sequencing technology). For this purpose, we employed the
online Primer map application. The same products as the obtained by the wet lab-PCR
were considered among all the predicted PCR products and the same patterns were
determined according to the product size. This approach confirmed the primer annealing
sites, and consequently, also allowed us to define the type of L-Cys transporter operon
in 213 out of 214 C. fetus strains (Table 2). The target annealing sites were highly conserved
because of the lack of nucleotide mismatches in these strains. The in silico-PCR was able to
predict the annealing sites for Fwd-Rev2 primers in the genome of Cfv Azul-94 but
the target sites were located into different contigs. The product size was difficult to estimate
and consequently this strain had inconclusive results (Table 2).
The hydrogen sulfide production data were available for 43/214 of the studied strains,
three from this study and forty from publicly available results (Van Bergen et al., 2005;
Van der Graaf-van Bloois et al., 2014, 2016a;Willoughby et al., 2005). However, two of the
evaluated strains have shown discrepant results according to the literature and were
excluded from this analysis. Interestingly, all of the H2S-producing strains displayed a
CFF/CFVI pattern, whereas the non- H2S-producing strains, with unequivocally
results according to the biochemical test, presented a CFV pattern (k = 1) (Table 2).
The analysis of concordance between in silico-PCR and H2S production is shown
in Table S3.
Table 1 (continued).












ND ND ND –
C. jejuni NCTC11392 National Collection of
Type Cultures, England
ND ND ND –
Notes:
“CFF/CFVI pattern” means that all the components of the L-Cys transporter are present and therefore, a product of 714
bp is obtained. “CFV pattern”means that the L-Cys transporter is deleted and a product of 310 bp is obtained. “−”means
that the amplification product was absent.
BA, Buenos Aires province; LP, La Pampa province; SF, Santa Fe province; ND, Not determined.
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Table 2 In silico-PCR: analysis of whole-genome sequence data.





Cff 04/554 Bovine Foetus AR CP008808–CP008809 + (Van der Graaf-van
Bloois et al., 2014)
CFF/CFVI
Cff 08/421 Bovine Foetus AR SOOT00000000 + (This study) CFF/CFVI
Cff 110800-21-2 Bovine Bull NL LSZN00000000 + (Van der Graaf-van
Bloois et al., 2014)
CFF/CFVI
Cff 13/344 Bovine Foetus AR SOYX00000000 + (This study) CFF/CFVI
Cff 82/40 Human Blood US CP000487 + (Van Bergen et al.,
2005)
CFF/CFVI
Cff Cff 98/v445 Bovine Bull UK LMBH00000000 + (Van Bergen et al.,
2005)
CFF/CFVI
Cff ATCC 27374 Ovine Foetus (brain) Unk. MKEI00000000 + (Van Bergen et al.,
2005)
CFF/CFVI
Cff BT 10/98 Ovine Unknown UK LRAL00000000 + (Van Bergen et al.,
2005)
CFF/CFVI
Cff NCTC10842 Unknown Unknown Unk. LS483431 + (Van Bergen et al.,
2005)
CFF/CFVI
Cff B0042 Bovine Feces UK ERR419595 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0047 Bovine Feces UK ERR419600 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0066 Bovine Feces UK ERR419653 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0097 Bovine Feces UK ERR419653 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0129 Bovine Feces UK ERR419637 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0130 Bovine Feces UK ERR419638 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0131 Bovine Feces UK ERR419639 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0151 Bovine Feces UK ERR419648 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0152 Bovine Feces UK ERR419649 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0167 Bovine Feces UK ERR460866 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff B0168 Bovine Feces UK ERR460867 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff S0693A Bovine Feces UK ERR419284 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cff S0478D Bovine Feces UK ERR419653 + (Van der Graaf-van
Bloois et al., 2016a)
CFF/CFVI
Cfvi 01/165 Bovine Mucus AR CP014568–CP014570 + (Van Bergen et al.,
2005)
CFF/CFVI
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Table 2 (continued).





Cfv 84/112 Bovine Genital secretion US HG004426–HG004427 − (Van Bergen et al.,
2005)
CFV
Cfv 97/608 Bovine Placenta AR CP008810–CP008812 − (Van Bergen et al.,
2005)
CFV
Cfv ADRI 1362 Bovine Unknown AR LREX00000000 + (Van der Graaf-van
Bloois et al., 2014)
CFF/CFVI
Cfv ADRI513 Unknown Unknown AU LRFA00000000 + (Van der Graaf-van
Bloois et al., 2014)
CFF/CFVI
Cfv B10 Bovine Unknown US LRET00000000 − (Van der Graaf-van
Bloois et al., 2014)
CFV





Cfv CCUG 33900 Bovine Abortion FR LREV00000000 − (Van der Graaf-van
Bloois et al., 2014)
CFV
Cfv LMG 6570 Bovine Unknown BE LREW00000000 − (Van Bergen et al.,
2005)
CFV
Cfv NCTC 10354 Bovine Mucus UK CM001228 − (Van Bergen et al.,
2005)
CFV
Cfv WBT 011/09 Unknown Unknown UK LMBI00000000 + (Van der Graaf-van
Bloois et al., 2014)
CFF/CFVI
Cfv zaf3 Bovine Foetus SA LREZ00000000 + (Van der Graaf-van
Bloois et al., 2014)
CFF/CFVI
Cfv zaf65 Bovine Unknown SA LREY00000000 + (Van der Graaf-van
Bloois et al., 2014)
CFF/CFVI
Cfvi 02/298 Bovine Foetus AR LRVK00000000 + (Van Bergen et al.,
2005)
CFF/CFVI
Cfvi 03/293 Bovine Foetus AR CP0006999–CP007002 + (Van Bergen et al.,
2005)
CFF/CFVI
Cfvi 03/596 Bovine Foetus AR LRAM00000000 + (Van Bergen et al.,
2005)
CFF/CFVI
Cfvi 06/341 Bovine Foetus AR SOYW00000000 + (This study) CFF/CFVI
Cfvi 92/203 Bovine Placenta AR LRVL00000000 + (Van Bergen et al.,
2005)
CFF/CFVI
Cfvi 97/532 Bovine Mucus AR LRER00000000 + (Van Bergen et al.,
2005)
CFF/CFVI
Cfvi/Cfv 98/25 Bovine Foetus AR LRES00000000 +/−/− (Van Bergen et al.,
2005; Van der
Graaf-van Bloois
et al., 2016a; This
study)
CFV
Cfvi 99/541 Bovine Prepuce AR ASTK00000000 + (Van Bergen et al.,
2005)
CFF/CFVI
Cff H1-UY Human Blood UY JYCP00000000 n.a CFF/CFVI
(Continued)
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Table 2 (continued).





Cff HC1 Human Blood UY QJTR00000000 n.a CFF/CFVI
Cff HC2 Human Cerebrospinal fluid UY QJTS00000000 n.a CFF/CFVI
Cff CIT01 Human Peripheral blood culture IR RBHV00000000 n.a CFF/CFVI
Cfv 642-21 Bovine Uterus AU AJSG00000000 n.a CFF/CFVI
Cfv 66Y Bovine Prepuce CA JPQC00000000 n.a CFV
Cfv Azul-94 Bovine Abortion AR ACLG00000000 n.a Unknown
Cfv B6 Bovine Vagina AU AJMC00000000 n.a CFV
Cfv TD Bovine Prepuce CA JPPC00000000 n.a CFV
Cf MMM01 Human Sepsis IN JRKX00000000 n.a CFF/CFVI
Cff 99/801 Bovine Prepuce AR ERS739235 n.a CFF/CFVI
Cff 00/398 Bovine Foetus AR ERS739236 n.a CFF/CFVI
Cff 00/564 Bovine Prepuce AR ERS739237 n.a CFF/CFVI
Cff 01/320 Bovine Foetus AR ERS739238 n.a CFF/CFVI
Cff 01/210 Bovine Vaginal mucus AR ERS739239 n.a CFF/CFVI
Cff 04/875 Bovine Foetus AR ERS739242 n.a CFF/CFVI
Cff 05/394 Bovine Foetus AR ERS739243 n.a CFF/CFVI
Cff 05/434 Bovine Vaginal mucus AR ERS739244 n.a CFF/CFVI
Cff 06/340 Bovine Prepuce AR ERS739245 n.a CFF/CFVI
Cff 07/485 Bovine Vaginal mucus AR ERS739248 n.a CFF/CFVI
Cff 08/362 Bovine Foetus AR ERS739249 n.a CFF/CFVI
Cff 10/247 Bovine Prepuce AR ERS739250 n.a CFF/CFVI
Cff 10/445 Bovine Prepuce AR ERS739251 n.a CFF/CFVI
Cff 11/360 Bovine Foetus AR ERS739252 n.a CFF/CFVI
Cff 11/427 Bovine Vaginal mucus AR ERS739253 n.a CFF/CFVI
Cff 14/270 Bovine Foetus AR ERS739254 n.a CFF/CFVI
Cff 15/301 Bovine Vaginal mucus AR ERS739255 n.a CFF/CFVI
Cfvi 02/146 Bovine Foetus AR ERS739240 n.a CFF/CFVI
Cfvi 06/195 Bovine Foetus AR ERS739246 n.a CFF/CFVI
Cfvi 07/379 Bovine Foetus AR ERS739247 n.a CFF/CFVI
Cff 2006/367h Human Cerebrospinal fluid FR ERS672242 n.a CFF/CFVI
Cff 2006/479h Human Feces FR ERS672243 n.a CFF/CFVI
Cff 2006/588h Human Cerebrospinal fluid FR ERS672244 n.a CFF/CFVI
Cff 2006/621h Human Blood FR ERS672245 n.a CFF/CFVI
Cff 2006/649h Human Feces FR ERS672246 n.a CFF/CFVI
Cff 2008/170h Human Feces FR ERS672247 n.a CFF/CFVI
Cff 2008/568h Human Joint fluid FR ERS672248 n.a CFF/CFVI
Cff 2008/604h Human Feces FR ERS672249 n.a CFF/CFVI
Cff 2008/691h Human Cerebrospinal fluid FR ERS672250 n.a CFF/CFVI
Cff 2008/755h Human Blood FR ERS672251 n.a CFF/CFVI
Cff 2008/898h Human Blood FR ERS672252 n.a CFF/CFVI
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Table 2 (continued).





Cff 2010/41h Human Feces FR ERS672253 n.a CFF/CFVI
Cff 2010/524h Human Kidney FR ERS672254 n.a CFF/CFVI
Cff 2010/1094h Human Blood FR ERS672255 n.a CFF/CFVI
Cff 2010/1119h Human Feces FR ERS672256 n.a CFF/CFVI
Cff 2010/1180h Human Blood FR ERS672257 n.a CFF/CFVI
Cff 2012/60h Human Feces FR ERS672258 n.a CFF/CFVI
Cff 2012/185h Human Blood FR ERS672259 n.a CFF/CFVI
Cff 2012/286h Human Blood FR ERS672260 n.a CFF/CFVI
Cff 2012/331h Human Blood FR ERS672261 n.a CFF/CFVI
Cff 2012/879h Human Feces FR ERS672263 n.a CFF/CFVI
Cff 2012/1045h Human Joint fluid FR ERS672264 n.a CFF/CFVI
Cff 2014/52h Human Cerebrospinal fluid FR ERS672265 n.a CFF/CFVI
Cff 2014/602h Human Blood FR ERS672266 n.a CFF/CFVI
Cff 2014/790h Human Blood FR ERS672267 n.a CFF/CFVI
Cff 2014/947h Human Blood FR ERS672269 n.a CFF/CFVI
Cff 2014/1097h Human Feces FR ERS672270 n.a CFF/CFVI
Cff 2007/123h Human Cerebrospinal fluid FR ERS672271 n.a CFF/CFVI
Cff 2009/56h Human Cerebrospinal fluid FR ERS672272 n.a CFF/CFVI
Cff CF156 Human Blood TR ERS672273 n.a CFF/CFVI
Cfvi 21-C0091-10-14_2 Bovine Prepuce UK ERS672276 n.a CFF/CFVI
Cff GTC _08732 Human Cerebrospinal fluid JP ERS672218 n.a CFF/CFVI
Cff GTC _11236 Human Feces JP ERS672220 n.a CFF/CFVI
Cff 96-48 Human Feces JP ERS672224 n.a CFF/CFVI
Cff 01-187 Human Blood JP ERS672226 n.a CFF/CFVI
Cff 2004/103h Human Cerebrospinal fluid FR ERS672233 n.a CFF/CFVI
Cff 2004/199h Human Cerebrospinal fluid FR ERS672234 n.a CFF/CFVI
Cff 2004/359h Human Blood FR ERS672235 n.a CFF/CFVI
Cff 2004/362h Human Placenta FR ERS672236 n.a CFF/CFVI
Cff 2004/526h Human Feces FR ERS672237 n.a CFF/CFVI
Cff 2004/598h Human Blood FR ERS672238 n.a CFF/CFVI
Cff 2004/605h Human Feces FR ERS672239 n.a CFF/CFVI
Cff 2004/637h Human Joint fluid FR ERS672240 n.a CFF/CFVI
Cff 2006/222h Human Blood FR ERS672241 n.a CFF/CFVI
Cff ID111063 Human Blood CA ERS739225 n.a CFF/CFVI
Cff ID117228 Human Blood CA ERS739226 n.a CFF/CFVI
Cff ID129038 Human Blood CA ERS739227 n.a CFF/CFVI
Cff ID131159 Human Feces CA ERS739228 n.a CFF/CFVI
Cff ID134381 Human Feces CA ERS739229 n.a CFF/CFVI
Cff ID136207 Human Blood CA ERS739230 n.a CFF/CFVI
Cff ID136551 Human Blood CA ERS739231 n.a CFF/CFVI
(Continued)
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Cff ID136656 Human Blood CA ERS739232 n.a CFF/CFVI
Cff ID136706 Human Blood CA ERS739233 n.a CFF/CFVI
Cff ID132939 Human Blood CA ERS739234 n.a CFF/CFVI
Cff 2975 Human Blood TW ERS739256 n.a CFF/CFVI
Cff 923 Human Blood TW ERS739257 n.a CFF/CFVI
Cff 7035 Human Blood TW ERS739258 n.a CFF/CFVI
Cff My5726 Human Blood TW ERS739259 n.a CFF/CFVI
Cff 1592 Human Blood TW ERS739260 n.a CFF/CFVI
Cff 1830 Human Blood TW ERS739261 n.a CFF/CFVI
Cff 8468 Human Blood TW ERS739262 n.a CFF/CFVI
Cff 0003304-2 Human Blood TW ERS739263 n.a CFF/CFVI
Cff 2115 Human Blood TW ERS739264 n.a CFF/CFVI
Cff 2819 Human Blood TW ERS739265 n.a CFF/CFVI
Cff 5871 Human Blood TW ERS739266 n.a CFF/CFVI
Cff 1666 Human Blood TW ERS739267 n.a CFF/CFVI
Cff 9502 Human Blood TW ERS739270 n.a CFF/CFVI
Cfv 800 Human Blood TW ERS739271 n.a CFF/CFVI
Cff 8031708 Human Blood TW ERS739272 n.a CFF/CFVI
Cff 8025552 Human Blood TW ERS739273 n.a CFF/CFVI
Cff 3069482 Human Blood TW ERS739274 n.a CFF/CFVI
Cfv C1 Bovine Prepuce SP ERS739275 n.a CFV
Cfv C2 Bovine Prepuce SP ERS739276 n.a CFV
Cff C3 Bovine Prepuce SP ERS739277 n.a CFF/CFVI
Cff C4 Bovine Prepuce SP ERS739278 n.a CFF/CFVI
Cff C5 Bovine Prepuce SP ERS739279 n.a CFF/CFVI
Cfv C6 Bovine Prepuce SP ERS739280 n.a CFF/CFVI
Cff C7 Bovine Prepuce SP ERS739281 n.a CFV
Cff C8 Bovine Prepuce SP ERS739282 n.a CFF/CFVI
Cff C11 Bovine Prepuce SP ERS739285 n.a CFF/CFVI
Cfvi C12 Bovine Prepuce SP ERS739286 n.a CFF/CFVI
Cff C13 Bovine Prepuce SP ERS739287 n.a CFF/CFVI
Cff C14 Bovine Prepuce SP ERS739288 n.a CFF/CFVI
Cff C15 Bovine Prepuce SP ERS739289 n.a CFF/CFVI
Cff C16 Bovine Prepuce SP ERS739290 n.a CFF/CFVI
Cff C17 Bovine Prepuce SP ERS739291 n.a CFF/CFVI
Cfv C19 Bovine Prepuce SP ERS739293 n.a CFV
Cff C20 Bovine Prepuce SP ERS739294 n.a CFF/CFVI
Cff C21 Bovine Prepuce SP ERS739295 n.a CFF/CFVI
Cfv C22 Bovine Prepuce SP ERS739296 n.a CFV
Cfv C23 Bovine Prepuce SP ERS739297 n.a CFV
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Cfv C24 Bovine Prepuce SP ERS739298 n.a CFV
Cfv C25 Bovine Prepuce SP ERS739299 n.a CFV
Cfvi C26 Bovine Prepuce SP ERS739300 n.a CFF/CFVI
Cfv C27 Bovine Prepuce SP ERS739301 n.a CFV
Cfvi C28 Bovine Prepuce SP ERS739302 n.a CFF/CFVI
Cff C29 Bovine Prepuce SP ERS739303 n.a CFF/CFVI
Cfv C30 Bovine Prepuce SP ERS739304 n.a CFV
Cfvi C31 Bovine Prepuce SP ERS739305 n.a CFF/CFVI
Cfvi C32 Bovine Prepuce SP ERS739306 n.a CFF/CFVI
Cfvi C33 Bovine Prepuce SP ERS739307 n.a CFF/CFVI
Cfv C34 Bovine Prepuce SP ERS739308 n.a CFF/CFVI
Cfv BS 201/02 Bovine Prepuce GE ERS686632 n.a CFV
Cfv BS 76/04 Bovine Foetus GE ERS686633 n.a CFV
Cfv BS 38/06 Bovine Prepuce GE ERS686634 n.a CFV
Cfv 07BS020 Bovine Prepuce GE ERS686635 n.a CFV
Cfv 08CS0024 Bovine Prepuce GE ERS686636 n.a CFF/CFVI
Cfv 09CS0030 Bovine Prepuce GE ERS686637 n.a CFV
Cfv 11CS0190 Bovine Prepuce GE ERS686638 n.a CFV
Cfv 11CS0191 Bovine Prepuce GE ERS686639 n.a CFV
Cfv 13CS0183 Bovine Prepuce GE ERS686640 n.a CFV
Cfv 14CS0001 Bovine Prepuce GE ERS686641 n.a CFV
Cff BS 456/99 Ovine Foetus GE ERS686642 n.a CFF/CFVI
Cff BS 458/99 Bovine Foetus GE ERS686643 n.a CFF/CFVI
Cff BS 03/04 Bovine Foetus GE ERS686644 n.a CFF/CFVI
Cff BS 91/05 Bovine Prepuce GE ERS686645 n.a CFF/CFVI
Cff 08CS0027 Bovine Prepuce GE ERS686646 n.a CFF/CFVI
Cff 11CS0098 Ovine Placenta GE ERS686648 n.a CFF/CFVI
Cff 12CS0302 Bovine Prepuce GE ERS686649 n.a CFF/CFVI
Cff 13CS0001 Bovine Prepuce GE ERS686650 n.a CFF/CFVI
Cff 13CS0373 Monkey Feces GE ERS686651 n.a CFF/CFVI
Cff 001A-0374 Human Blood CA ERS686652 n.a CFF/CFVI
Cff 001A-0648 Human Blood CA ERS686653 n.a CFF/CFVI
Cff LR133 Ovine Foetus NZ ERS846544 n.a CFF/CFVI
Cff 1 Bovine Prepuce UK ERS846553 n.a CFF/CFVI
Cff 2 Bovine Prepuce UK ERS846554 n.a CFF/CFVI
Cff 3 Ovine Placenta UK ERS846555 n.a CFF/CFVI
Cff 4 Ovine Placenta UK ERS846556 n.a CFF/CFVI
Cff 5 Ovine Placenta UK ERS846557 n.a CFF/CFVI
Cff 6 Bovine Prepuce UK ERS846558 n.a CFF/CFVI
Cff 7 Ovine Foetus UK ERS846559 n.a CFF/CFVI
(Continued)
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Despite this concordance with the H2S-production test, 14 out of 43 strains that were
identified as Cfv in the database did not match with the criteria of the deleted L-Cys
transporter for this subspecies. Instead, these strains displayed a CFF/CFVI pattern
(Table 2). This situation is also reflected by the overall analysis where the in silico study
was able to assign the expected result in 92% (197/213) of the strains (one strain with
inconclusive subspecies identification was excluded from the analysis). This partial
discrepancy could be attributed to the different methods employed to determine
subspecies and this information is not available for most of the strains used in this analysis.
As a proof of concept, we assessed six local field isolates (Cff 08-421, Cff 13-344,
Cfv 97-608, Cfv 98-25, Cfvi INTA 99/541 and Cfvi 06-341) through the wet-lab and in
silico-PCR approaches. The strains Cfv 97-608, Cfv 98-25 and Cfvi INTA 99/541 were
selected from the C. fetus collection because of their genomic sequence availability
(Van der Graaf-van Bloois et al., 2016a; Iraola et al., 2013). The L-Cys-transporter-PCR
results perfectly matched the in silico-PCR predictions (Tables 1 and 2).
Altogether, this study showed a strong concordance between the results of the L-Cys
transporter-PCR and the H2S-production test for C. fetus analysis. Furthermore, it
highlights the lack of consensus in the classification of these bacteria between the different
laboratories around the world.
DISCUSSION
To date, phenotypic tests are among the most valuable methods to identify and
differentiate microorganisms. However, these tests are usually time-consuming, because
they are growth-rate dependent, and the whole process depends on the objectivity and
skills of the operator. Furthermore, a proper standardization, which is essential to obtain
reliable and reproducible results, is often absent. Despite all this, the replacement of
Table 2 (continued).





Cff 8 Ovine Foetus UK ERS846560 n.a CFF/CFVI
Cff 9 Ovine Placenta UK ERS846561 n.a CFF/CFVI
Cff 12 Ovine Placenta UK ERS846562 n.a CFF/CFVI
Cff 13 Bovine Prepuce UK ERS846563 n.a CFF/CFVI
Cff 14 Ovine Placenta UK ERS846564 n.a CFF/CFVI
Cff 15 Ovine Placenta UK ERS846565 n.a CFF/CFVI
Cff 17 Ovine Foetus UK ERS846566 n.a CFF/CFVI
Cfv JCM_2528 Bovine Vaginal mucus UK ERS846567 n.a CFF/CFVI
Cfv 161/97 Bovine Prepuce BR ERS846568 n.a CFF/CFVI
Cfv 515/98 Bovine Prepuce BR ERS846569 n.a CFF/CFVI
Notes:
“CFF/CFVI pattern” means that a complete L-Cys transporter is present. Hybridization of the primer pair Fwd-Rev1-template should occur and a product of 714 bp is
predicted. “CFV pattern”means that the L-Cys transporter is partially deleted. Hybridization of the primer pair Fwd-Rev2-template should occur and a product of 310 bp
is predicted.
Country code: US, United States; AR, Argentina; UK, United Kingdom; CZ, Czech Republic; FR, France; AU, Australia; CA, Canada; SA, South Africa; NL, The
Netherlands; UY, Uruguay; BE, Belgium; IR, Ireland; IN, India; TR, Turkey; JP, Japan; TW, Taiwan; SP, Spain; GE, Germany; BR, Brazil. N.A: Not available.
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these phenotypic tests by molecular techniques is not always an alternative to date.
The antimicrobial resistance constitutes a good example of complementary testing, and
this particular phenotypic trait can be tested by bacteriological methods and at molecular
level in several pathogens (Fluit, Visser & Schmitz, 2001).
Over the last years, researchers have proposed many genotypic tests to facilitate C. fetus
differentiation. For example, different studies have employed molecular techniques such as
PCR based on different target genes to differentiate Cfv from Cff (Hum et al., 1997;
Van Bergen et al., 2005; Abril et al., 2007). However, to date there is no clear consensus on
the best method to assess C. fetus subspecies. The main problems rise from the limited
number of tested strains, the failure to identify Cfvi strains and the low concordance with
other techniques such as AFLP and, mainly, biochemical tests (Willoughby et al., 2005;
Schulze et al., 2006; Schmidt, Venter & Picard, 2010).
A genome-wide association study has proposed the association between candidate gene
loci coding for the L-Cys transporter and the H2S production, which together to glycine
resistance is one of the phenotypic traits available for assessing C. fetus subspecies to
date. According to this, H2S-producing C. fetus strains, commonly classified as Cff and
Cfvi, have a complete L-Cys transporter operon, whereas the non-producing H2S C. fetus
strains, classically classified as Cfv, have a deleted L-Cys transporter. It is important to
mention that C. fetus subsp. testudinum (Cft), the last subspecies proposed of C. fetus, has a
complete version of the operon. This is the case of the strain Cft 03/427 (whose
genome is the representative of the species) which has been concordantly described as
an H2S-producing strain elsewhere (Van der Graaf-van Bloois et al., 2016a). To date, this
subspecies has not been described in cattle, and for this reason it was excluded of
this study.
In this work, we have designed a multiplex-PCR protocol to provide a molecular tool to
contribute to C. fetus characterization and differentiation. This L-Cys transporter-PCR
showed an excellent correlation with the H2S production test according to both wet lab and
in silico approaches. As other molecular techniques, this PCR failed to differentiate
Cff from Cfvi strains. This will limit its use in countries where this biovar is prevalent.
However, until more discriminative techniques are developed, its usefulness could be
further enhanced by combining this technique with other complementary test, such as the
glycine resistance assay.
In addition to practical implications of this tool in the laboratory, this study also
contributes to the existing debate around C. fetus subspecies classification.
In this study, we tested C. fetus strains isolated and typed at the Bacteriology Unit of
INTA-Balcarce (Argentina), which has a long history in culturing this bacterium and in
performing its biochemical based classification. In this way, the wet-lab approach showed
a perfect correlation not only with the H2S production test, but also with the C. fetus
subspecies. Indeed, a CFF-CFVI pattern, which is indicative of L-Cys complete transporter,
was associated with H2S-producing strains typically classified as Cff or Cfvi. By contrast, a
CFV pattern, which is indicative of a deleted transporter, was exclusively associated
with H2S-non-producing strains, which are typically classified as Cfv.
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On the other hand, when we performed the in silico study, we analyzed genomic data
from strains classified elsewhere by both molecular based approaches and/or biochemical
tests and, as mentioned above, both techniques frequently displayed discordant results.
In this way, we have obtained a perfect correlation with the H2S production test, but
not with the reported subspecies of the strains.
This discordancy is well reflected by the strain 98-25. Researchers from the Bacteriology
Unit of INTA-Balcarce isolated this strain in 1998 from aborted foetus, and originally
typed it as Cfv because of its glycine sensitivity and its inability to produce H2S. This strain
was included in this study and the PCR-L-Cys result was concordant with the phenotype
of this strain. Later studies have also tested this strain and successfully sequenced its
genome. Indeed, Van Bergen et al. (2005) typed it as glycine sensitive and H2S positive
(typical traits of Cfvi strains). Later, Van der Graaf-van Bloois et al. (2014) reported it as
non-H2S-producing strain. However, in this latter work, it has been called Cfvi 98-25
regardless the biochemical traits reported. In our study, the in silico sequence data
analysis revealed the polymorphism of the L-Cys transporter (CFV pattern) typical of
the non- H2S- producing strains.
Therefore, the same strain could display different biochemical traits when assayed in
different labs -or time- and this is the classical bottle-neck of phenotypic tests.
We initially had other discrepancies with some isolates. Remarkably, 14 out of 43 Cfv
genomic sequences tested in silico showed a complete version of the L-Cys transporter
(CFF/CFVI pattern). Hence, at first glance, the hypothesis that all Cfv isolates do have
a deleted L-Cys transporter appeared as not valid, according to the in silico analysis.
However, when we searched the biochemical tests reported for some of these strains,
we concluded that the in silico results presented here were concordant with the H2S
production test. This discrepancy with the subspecies assigned could be due to the
classification method of the strains that is frequently based on molecular techniques
regardless the biochemical test results and moreover; the chosen method is not always
specified (Iraola et al., 2017). Altogether, the in silico analysis also supports the hypothesis
that states the occurrence of a deletion in the transporter operon in non-H2S producing
strains, which are classified as Cfv according to biochemical methods.
As was mentioned earlier, it is important to highlight that the strains from databases
are not typed by the same methodology and this fact is not always taken into account.
Consequently, this could be problematic as our study showed. The most widespread
molecular-based method is the multiplex-PCR described by Hum et al. (1997). This PCR
targets the parA gene to identify Cfv strains. This transfer-associated gene is harbored
in a pathogenicity island which encodes a Type 4 Secretion System (T4SS). Although
the presence of a T4SS has been previously associated to Cfv strains (Gorkiewicz et al.,
2010), it has also been demonstrated later that some Cff strains can harbor the T4SS
and their related genes (Van der Graaf-van Bloois et al., 2016b). Furthermore, distinct
phylogenetic analyses of C. fetus suggest that the current classification in subspecies must
be redefined. A phylogenomic study based on the core genome have shown that the
strains are divided in two clusters. While all the Cfv and Cfvi strains were grouped
in one genome cluster, the Cff strains were equally distributed in both clusters
Farace et al. (2019), PeerJ, DOI 10.7717/peerj.7820 16/21
(Van der Graaf-van Bloois et al., 2014). Additionally, a phylogenetic reconstruction
based on the divergence acquired by recombination have also shown that Cfv and Cff
strains share the same clade, which differs clearly from the clade of Cft strains of
reptile origin (Gilbert et al., 2018). This emphasizes a real need to go further toward
current C. fetus classification and identification, which will have a significant impact
on the diagnostic practice. As mentioned above, although this issue has been
addressed in the literature and genomic studies have broadened and strengthened our
knowledge of this bacterium (Van der Graaf-van Bloois et al., 2014, 2016a; Iraola
et al., 2017), a concerted action toward C. fetus subspecies classification and
differentiation has been neglected. There are no molecular markers associated to
tropism or virulence of Cfv that could help with a differential diagnosis of the BGC
(Gilbert et al., 2018).
Consequently, in light of these evidences, more research is essential to determine, as a
first step, whether the differential diagnosis should be promoted and, if so, to improve or
replace definitively the tests currently available. Another point to consider is that,
veterinary diagnostic laboratories from developing countries are often refractory to
replace those methods that have proven be useful, even if they are not the most suitable
ones. Because of that, the adoption of genetic or even genomic-based methods has
been delayed. One possible reason is the cost related to each method. The second
main reason is the time lapse it takes for scientific knowledge to reach end users.
Interdisciplinary research combining genomics, biochemistry, epidemiology and the
provision of updated information and training to end users could shed light on this
matter in the near future.
CONCLUSIONS
Biochemical tests including tolerance to glycine and H2S production are currently
recommended by the OIE (2018) for C. fetus subspecies differentiation and are still
employed in laboratories around the world. Thus, a molecular tool linked to a phenotypic
trait is a valuable tool that could be more accurate and less time consuming than the
available phenotypic tests. Mutagenesis and functional studies are essential to associate
definitely this putative L-Cys transporter with the H2S production. Meanwhile, this
study shows that this transporter constitutes a good marker that is useful for detecting
H2S-producing C. fetus. Future actions will be addressed to test the L-Cys-PCR in clinical
samples to propose it not only as a typing method, but as a detection technique and,
as a second phase of validation, to transfer this technology to other labs to test the
reproducibility of the results.
Finally, this work provides a molecular tool linked to H2S production in C. fetus
and supports the findings of the pioneering study of Van der Graaf-van Bloois
et al. (2016a).
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